We are dedicated to providing our patients with the highest quality eye care incorporating the latest science and technology available to our profession. This is why we would like to share with you an important advancement in the management of Age-related Macular Degeneration (AMD), which is the leading cause of blindness in the United States.
We are now offering a genetic test to patients who have a diagnosis of early or intermediate AMD. Using the complete combination of AMD genes and smoking history, the test identifies those most likely to progress to advanced AMD with vision loss. The test is a simple cheek swab that gets sent to a testing lab, and the results are returned to our office within four weeks. Most healthcare insurers including Medicare reimburse the test.
The test allows us to identify whether you are at an elevated risk of advancing to the more severe form of the disease because of a genetic predisposition. Knowing your risk of progression can help us better monitor and manage your disease with the goal of protecting your vision long term. Click the image below to visit the macula risk genetic testing website and learn more.
